Lung Cancer Vaccines: Pipeline, Strategies and Clinical

1
Aarkstore.com Lung Cancer Vaccines Pipeline,
Strategies and Clinical
2
Summary

• This report provides a comprehensive review of 42
  candidate vaccines that are being evaluated for
  the treatment of lung cancer, covering pipeline,
  disease-targeting strategies and clinical
  findings. These vaccines are directed at 24
  antigens or antigen combinations. Globally,
  lung cancer is the most common cancer and in 2008
  there were an estimated 1.6 million new cases and
  1.4 million deaths (almost 20 of all cancer
  deaths) caused by this disease. Five-year
  survival rates are also low (15-20) compared to
  other common cancers. In the US, studies have
  shown that lung cancer-care costs (in 2006) were
  the third highest of all cancers, while indirect
  costs (2005) were higher than for any other
  cancer. Patient needs and the high burden of
  lung cancer drive the development of new
  therapies. While improvements have been seen in
  diagnosis and treatments (surgery, radiotherapy,
  chemotherapy and targeted drugs), new therapies
  that build on the capabilities of existing
  approaches, are urgently required. Today,
  developments continue to be made in drug
  treatments for lung cancer in chemotherapy, new
  drug combinations and targeted molecules. In
  particular, advances are being seen in the field
  of immunotherapy in the development of new
  therapeutic antibodies and therapeutic vaccines.

3
Table of Contents

• Summary1 Lung Cancer1.1 Statistics1.2
  Diagnosis1.3 Lung Cancer Staging1.4 Treatment
  of Lung Cancer1.5 Survival Rates1.6 Cost of
  Lung Cancer1.7 New Developments1.8 This
  ReportReferencesChapter 2 Approved and
  Late-Stage VaccinesSummary2.1 Introduction2.2
  Overview2.3 (One vaccine, Approved)2.4 2.6
  (Three vaccines, Phase 3)2.7 (One vaccine, Phase
  2/3)References

4
More Related Reports

•   VEGF Inhibition Therapy-Indicating and
  Prognostic Biomarkers, 2011
•   Biomarkers in Alzheimers Disease, 2011
•   Alzheimers Disease Autoantibodies, Vaccines
  and Therapeutic Antibodies Pipeline, 2011
•   Prostate Cancer Vaccines and Therapeutic
  Antibodies Pipeline, 2011
•   Breast Cancer Vaccines and Therapeutic
  Antibodies Pipeline, 2011
•   Alzheimers Disease Biomarkers in Cerebrospinal
  Fluid and Blood, 2011
•   Image-Based Biomarkers in Alzheimers Disease,
  2011
•   Lung Cancer Vaccines and Therapeutic
  Antibodies Pipeline, Strategies and Clinical

5
For More details

• http//www.aarkstore.com/reports/Lung-Cancer-Vacci
  nes-Pipeline-Strategies-and-Clinical-157139.html
• Vina
• Aarkstore.com
• Contact Marketing team
• Mob.No.918149852585
• Email enquiry_at_aarkstore.com
• URL http//www.aarkstore.com/
• XML http//www.aarkstore.com/feeds/Biopharmrepor
  ts.xml